NTHI · Neonc Technologies Holdings, Inc. · Executive Compensation
$2.77
+0.05 (+1.84%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company's ability to continue as a going concern one year from the issuance date of this Form 10-Q. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company is actively taking steps to mitigate the substantial doubt about the Company's ability to continue as a going concern, including pursuing additional financing.”View the 10-Q filed Aug 10, 2026
Market Cap
$70.55M
Shares
25.94M
Volume · Oct 20
102.23K
Avg daily vol (3M)
196.11K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ali Mohammad Ahmad Alabedin | director | Appointed | 2026-10-15 |
| Steven L. Giannotta, M.D. | Class I director | Resigned | 2026-10-15 |
| Nasim Shomali | a director | Appointed | 2026-07-02 |
| Ming-Fu (Alan) Chiang, M.D., Ph.D., MBA | Scientific Advisory Board | Resigned | 2026-07-02 |
| Ming-Fu (Alan) Chiang, M.D., Ph.D., MBA | a Class II director | Resigned | 2026-07-02 |
| David Choi | Chief Accounting Officer | Appointed | 2026-03-17 |
| David Choi | Chief Accounting Officer | Appointed | 2026-03-17 |
| Dr. Ming-Fu Chiang | director | Appointed | 2025-11-14 |
| Ishwar K. Puri | Board of Directors | Resigned | 2025-11-14 |
| Amir Heshmatpour | Chief Executive Officer | Appointed | 2025-11-06 |
| Dr. Thomas Chen | Chief Medical Officer and Chief Scientific Officer | Appointed | 2025-11-06 |
| Dr. Thomas Chen | Chief Executive Officer | Resigned | 2025-11-06 |
| Ishwar Puri | director | Appointed | 2025-08-22 |
| Dr. Ming-Fu Chiang | the Board | Resigned | 2025-08-22 |
| Josh Neman | Chief Clinical Officer | Appointed | 2025-06-06 |
| Patrick Walters | Chief Operating Officer | Retired | 2025-06-03 |
| Amir Heshmatpour | President | Appointed | 2025-04-11 |
Leadership
- Amir Heshmatpour CEO
- Thomas C. Chen Chairman
- Keithly Garnett CFO
- David Choi Chief Accounting Officer
- David Suh Chief Accounting Officer
- Ali Mohammad Ahmad Alabedin Board Member
- Bader Almonawer Board Member
- Ishwar Puri Board Member
- Jim Delshad Board Member
- Nasim Shomali Board Member
- Victoria Medvec Board Member